nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP2C8—Tazarotene—psoriasis	0.0541	0.0787	CbGbCtD
Diltiazem—CYP3A5—Beclomethasone—psoriasis	0.0523	0.0761	CbGbCtD
Diltiazem—CYP2D6—Hydroxyurea—psoriasis	0.0243	0.0354	CbGbCtD
Diltiazem—CACNA1S—pes—psoriasis	0.0238	0.804	CbGeAlD
Diltiazem—CYP2C8—Cholecalciferol—psoriasis	0.0231	0.0336	CbGbCtD
Diltiazem—CYP3A7—Hydrocortisone—psoriasis	0.0223	0.0324	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0223	0.0324	CbGbCtD
Diltiazem—CYP3A7—Cyclosporine—psoriasis	0.021	0.0306	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.021	0.0306	CbGbCtD
Diltiazem—CYP3A5—Mycophenolate mofetil—psoriasis	0.0208	0.0303	CbGbCtD
Diltiazem—CYP2C8—Mycophenolate mofetil—psoriasis	0.02	0.0291	CbGbCtD
Diltiazem—CYP2C19—Cholecalciferol—psoriasis	0.0194	0.0282	CbGbCtD
Diltiazem—CYP3A4—Calcitriol—psoriasis	0.0182	0.0265	CbGbCtD
Diltiazem—CYP3A5—Hydrocortisone—psoriasis	0.0167	0.0243	CbGbCtD
Diltiazem—CYP2C9—Cholecalciferol—psoriasis	0.0161	0.0234	CbGbCtD
Diltiazem—CYP2C8—Hydrocortisone—psoriasis	0.0161	0.0234	CbGbCtD
Diltiazem—CYP3A5—Cyclosporine—psoriasis	0.0158	0.023	CbGbCtD
Diltiazem—CYP2C8—Cyclosporine—psoriasis	0.0152	0.0221	CbGbCtD
Diltiazem—CYP2D6—Cholecalciferol—psoriasis	0.0147	0.0214	CbGbCtD
Diltiazem—CYP3A4—Methoxsalen—psoriasis	0.0141	0.0206	CbGbCtD
Diltiazem—CYP3A7—Dexamethasone—psoriasis	0.0139	0.0202	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0139	0.0202	CbGbCtD
Diltiazem—ABCB1—Mycophenolate mofetil—psoriasis	0.0136	0.0197	CbGbCtD
Diltiazem—CYP2C19—Prednisone—psoriasis	0.0134	0.0195	CbGbCtD
Diltiazem—CYP2C19—Cyclosporine—psoriasis	0.0127	0.0185	CbGbCtD
Diltiazem—ABCB1—Betamethasone—psoriasis	0.0116	0.0169	CbGbCtD
Diltiazem—ABCB1—Prednisolone—psoriasis	0.0115	0.0167	CbGbCtD
Diltiazem—ABCB1—Hydrocortisone—psoriasis	0.0109	0.0158	CbGbCtD
Diltiazem—ABCB1—Prednisone—psoriasis	0.0108	0.0158	CbGbCtD
Diltiazem—CYP2C9—Cyclosporine—psoriasis	0.0106	0.0154	CbGbCtD
Diltiazem—CYP3A5—Dexamethasone—psoriasis	0.0104	0.0151	CbGbCtD
Diltiazem—ABCB1—Cyclosporine—psoriasis	0.0103	0.0149	CbGbCtD
Diltiazem—CYP2C8—Dexamethasone—psoriasis	0.00999	0.0145	CbGbCtD
Diltiazem—CYP2D6—Cyclosporine—psoriasis	0.00968	0.0141	CbGbCtD
Diltiazem—CYP3A4—Cholecalciferol—psoriasis	0.00937	0.0136	CbGbCtD
Diltiazem—CYP2C19—Dexamethasone—psoriasis	0.00838	0.0122	CbGbCtD
Diltiazem—CYP3A4—Mycophenolate mofetil—psoriasis	0.00812	0.0118	CbGbCtD
Diltiazem—CYP3A4—Triamcinolone—psoriasis	0.00812	0.0118	CbGbCtD
Diltiazem—CYP2C9—Dexamethasone—psoriasis	0.00697	0.0101	CbGbCtD
Diltiazem—CYP3A4—Betamethasone—psoriasis	0.00697	0.0101	CbGbCtD
Diltiazem—CYP3A4—Prednisolone—psoriasis	0.00687	0.01	CbGbCtD
Diltiazem—ABCB1—Dexamethasone—psoriasis	0.00676	0.00984	CbGbCtD
Diltiazem—CYP3A4—Hydrocortisone—psoriasis	0.00652	0.00948	CbGbCtD
Diltiazem—CYP3A4—Prednisone—psoriasis	0.00649	0.00944	CbGbCtD
Diltiazem—CYP2D6—Dexamethasone—psoriasis	0.00637	0.00927	CbGbCtD
Diltiazem—CYP3A4—Cyclosporine—psoriasis	0.00615	0.00895	CbGbCtD
Diltiazem—ABCB1—Methotrexate—psoriasis	0.00544	0.00791	CbGbCtD
Diltiazem—CYP3A4—Dexamethasone—psoriasis	0.00405	0.0059	CbGbCtD
Diltiazem—CACNG1—tendon—psoriasis	0.00398	0.134	CbGeAlD
Diltiazem—CACNA1S—tendon—psoriasis	0.00183	0.0616	CbGeAlD
Diltiazem—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00119	0.0484	CbGpPWpGaD
Diltiazem—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.00118	0.048	CbGpPWpGaD
Diltiazem—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00106	0.0432	CbGpPWpGaD
Diltiazem—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000978	0.0398	CbGpPWpGaD
Diltiazem—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00097	0.0394	CbGpPWpGaD
Diltiazem—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000913	0.0371	CbGpPWpGaD
Diltiazem—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000853	0.0347	CbGpPWpGaD
Diltiazem—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000739	0.03	CbGpPWpGaD
Diltiazem—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000659	0.0268	CbGpPWpGaD
Diltiazem—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000606	0.0247	CbGpPWpGaD
Diltiazem—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000601	0.0244	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL22—psoriasis	0.000516	0.021	CbGpPWpGaD
Diltiazem—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00049	0.0199	CbGpPWpGaD
Diltiazem—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000483	0.0197	CbGpPWpGaD
Diltiazem—CACNA1S—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000454	0.0185	CbGpPWpGaD
Diltiazem—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000397	0.0161	CbGpPWpGaD
Diltiazem—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000396	0.0161	CbGpPWpGaD
Diltiazem—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000354	0.0144	CbGpPWpGaD
Diltiazem—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000349	0.0142	CbGpPWpGaD
Diltiazem—CACNA1C—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000324	0.0132	CbGpPWpGaD
Diltiazem—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000307	0.0125	CbGpPWpGaD
Diltiazem—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000303	0.0123	CbGpPWpGaD
Diltiazem—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000287	0.0117	CbGpPWpGaD
Diltiazem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000274	0.0111	CbGpPWpGaD
Diltiazem—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00027	0.011	CbGpPWpGaD
Diltiazem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000252	0.0102	CbGpPWpGaD
Diltiazem—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00025	0.0101	CbGpPWpGaD
Diltiazem—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000249	0.0101	CbGpPWpGaD
Diltiazem—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000249	0.0101	CbGpPWpGaD
Diltiazem—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000246	0.01	CbGpPWpGaD
Diltiazem—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000222	0.00902	CbGpPWpGaD
Diltiazem—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000214	0.00869	CbGpPWpGaD
Diltiazem—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000211	0.00858	CbGpPWpGaD
Diltiazem—CACNA1S—Alzheimers Disease—APOE—psoriasis	0.00021	0.00854	CbGpPWpGaD
Diltiazem—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000208	0.00846	CbGpPWpGaD
Diltiazem—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000204	0.0083	CbGpPWpGaD
Diltiazem—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000202	0.00823	CbGpPWpGaD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.000181	0.00735	CbGpPWpGaD
Diltiazem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000165	0.00669	CbGpPWpGaD
Diltiazem—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000162	0.00661	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000152	0.0062	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.00015	0.00611	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—APOE—psoriasis	0.00015	0.00609	CbGpPWpGaD
Diltiazem—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000133	0.00543	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000132	0.00537	CbGpPWpGaD
Diltiazem—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000132	0.00535	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.00013	0.0053	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.000129	0.00524	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000127	0.00515	CbGpPWpGaD
Diltiazem—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000123	0.00499	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000118	0.00479	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000116	0.00473	CbGpPWpGaD
Diltiazem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000115	0.00466	CbGpPWpGaD
Diltiazem—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000114	0.00465	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000108	0.00441	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000108	0.00437	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000107	0.00435	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000106	0.00431	CbGpPWpGaD
Diltiazem—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000105	0.00427	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—CARM1—psoriasis	0.000101	0.00412	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—HLA-C—psoriasis	9.78e-05	0.00398	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL13—psoriasis	9.72e-05	0.00395	CbGpPWpGaD
Diltiazem—CACNA1S—Alzheimers Disease—TNF—psoriasis	9.72e-05	0.00395	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL17A—psoriasis	8.95e-05	0.00364	CbGpPWpGaD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—IL6—psoriasis	8.84e-05	0.00359	CbGpPWpGaD
Diltiazem—CACNA1S—Alzheimers Disease—TP53—psoriasis	8.57e-05	0.00348	CbGpPWpGaD
Diltiazem—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.56e-05	0.00348	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL12B—psoriasis	8.32e-05	0.00338	CbGpPWpGaD
Diltiazem—Alopecia—Prednisone—psoriasis	8.15e-05	0.000315	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.12e-05	0.0033	CbGpPWpGaD
Diltiazem—Loss of consciousness—Betamethasone—psoriasis	8.1e-05	0.000314	CcSEcCtD
Diltiazem—Loss of consciousness—Dexamethasone—psoriasis	8.1e-05	0.000314	CcSEcCtD
Diltiazem—Dizziness—Mycophenolic acid—psoriasis	8.1e-05	0.000313	CcSEcCtD
Diltiazem—Epistaxis—Methotrexate—psoriasis	8.1e-05	0.000313	CcSEcCtD
Diltiazem—Paraesthesia—Prednisolone—psoriasis	8.1e-05	0.000313	CcSEcCtD
Diltiazem—Tachycardia—Triamcinolone—psoriasis	8.09e-05	0.000313	CcSEcCtD
Diltiazem—Malnutrition—Prednisone—psoriasis	8.03e-05	0.000311	CcSEcCtD
Diltiazem—Erythema—Prednisone—psoriasis	8.03e-05	0.000311	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.02e-05	0.00031	CcSEcCtD
Diltiazem—Hyperhidrosis—Triamcinolone—psoriasis	8.02e-05	0.00031	CcSEcCtD
Diltiazem—Agranulocytosis—Methotrexate—psoriasis	8.01e-05	0.00031	CcSEcCtD
Diltiazem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.99e-05	0.00325	CbGpPWpGaD
Diltiazem—Feeling abnormal—Mycophenolate mofetil—psoriasis	7.97e-05	0.000308	CcSEcCtD
Diltiazem—Insomnia—Hydrocortisone—psoriasis	7.96e-05	0.000308	CcSEcCtD
Diltiazem—Paraesthesia—Hydrocortisone—psoriasis	7.91e-05	0.000306	CcSEcCtD
Diltiazem—Urticaria—Cyclosporine—psoriasis	7.87e-05	0.000305	CcSEcCtD
Diltiazem—Myalgia—Dexamethasone—psoriasis	7.85e-05	0.000304	CcSEcCtD
Diltiazem—Myalgia—Betamethasone—psoriasis	7.85e-05	0.000304	CcSEcCtD
Diltiazem—Body temperature increased—Cyclosporine—psoriasis	7.83e-05	0.000303	CcSEcCtD
Diltiazem—Abdominal pain—Cyclosporine—psoriasis	7.83e-05	0.000303	CcSEcCtD
Diltiazem—Vomiting—Mycophenolic acid—psoriasis	7.79e-05	0.000301	CcSEcCtD
Diltiazem—Discomfort—Dexamethasone—psoriasis	7.75e-05	0.0003	CcSEcCtD
Diltiazem—Discomfort—Betamethasone—psoriasis	7.75e-05	0.0003	CcSEcCtD
Diltiazem—Dyspepsia—Hydrocortisone—psoriasis	7.75e-05	0.0003	CcSEcCtD
Diltiazem—Rash—Mycophenolic acid—psoriasis	7.72e-05	0.000299	CcSEcCtD
Diltiazem—Dermatitis—Mycophenolic acid—psoriasis	7.72e-05	0.000299	CcSEcCtD
Diltiazem—Pain—Prednisolone—psoriasis	7.71e-05	0.000298	CcSEcCtD
Diltiazem—Hepatitis—Methotrexate—psoriasis	7.71e-05	0.000298	CcSEcCtD
Diltiazem—Urticaria—Mycophenolate mofetil—psoriasis	7.68e-05	0.000297	CcSEcCtD
Diltiazem—Headache—Mycophenolic acid—psoriasis	7.67e-05	0.000297	CcSEcCtD
Diltiazem—Decreased appetite—Hydrocortisone—psoriasis	7.65e-05	0.000296	CcSEcCtD
Diltiazem—Pharyngitis—Methotrexate—psoriasis	7.65e-05	0.000296	CcSEcCtD
Diltiazem—Abdominal pain—Mycophenolate mofetil—psoriasis	7.64e-05	0.000296	CcSEcCtD
Diltiazem—Body temperature increased—Mycophenolate mofetil—psoriasis	7.64e-05	0.000296	CcSEcCtD
Diltiazem—Urinary tract disorder—Methotrexate—psoriasis	7.61e-05	0.000295	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.6e-05	0.000294	CcSEcCtD
Diltiazem—Fatigue—Hydrocortisone—psoriasis	7.59e-05	0.000294	CcSEcCtD
Diltiazem—Vision blurred—Prednisone—psoriasis	7.57e-05	0.000293	CcSEcCtD
Diltiazem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.56e-05	0.00307	CbGpPWpGaD
Diltiazem—Urethral disorder—Methotrexate—psoriasis	7.56e-05	0.000292	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.55e-05	0.000292	CcSEcCtD
Diltiazem—Pain—Hydrocortisone—psoriasis	7.53e-05	0.000291	CcSEcCtD
Diltiazem—Oedema—Dexamethasone—psoriasis	7.52e-05	0.000291	CcSEcCtD
Diltiazem—Oedema—Betamethasone—psoriasis	7.52e-05	0.000291	CcSEcCtD
Diltiazem—Insomnia—Triamcinolone—psoriasis	7.5e-05	0.00029	CcSEcCtD
Diltiazem—Infection—Dexamethasone—psoriasis	7.47e-05	0.000289	CcSEcCtD
Diltiazem—Infection—Betamethasone—psoriasis	7.47e-05	0.000289	CcSEcCtD
Diltiazem—Ill-defined disorder—Prednisone—psoriasis	7.45e-05	0.000288	CcSEcCtD
Diltiazem—Paraesthesia—Triamcinolone—psoriasis	7.45e-05	0.000288	CcSEcCtD
Diltiazem—Feeling abnormal—Prednisolone—psoriasis	7.43e-05	0.000288	CcSEcCtD
Diltiazem—Visual impairment—Methotrexate—psoriasis	7.43e-05	0.000287	CcSEcCtD
Diltiazem—Shock—Dexamethasone—psoriasis	7.4e-05	0.000286	CcSEcCtD
Diltiazem—Shock—Betamethasone—psoriasis	7.4e-05	0.000286	CcSEcCtD
Diltiazem—Dyspnoea—Triamcinolone—psoriasis	7.39e-05	0.000286	CcSEcCtD
Diltiazem—Nervous system disorder—Dexamethasone—psoriasis	7.38e-05	0.000286	CcSEcCtD
Diltiazem—Nervous system disorder—Betamethasone—psoriasis	7.38e-05	0.000286	CcSEcCtD
Diltiazem—Thrombocytopenia—Betamethasone—psoriasis	7.37e-05	0.000285	CcSEcCtD
Diltiazem—Thrombocytopenia—Dexamethasone—psoriasis	7.37e-05	0.000285	CcSEcCtD
Diltiazem—Tachycardia—Betamethasone—psoriasis	7.34e-05	0.000284	CcSEcCtD
Diltiazem—Tachycardia—Dexamethasone—psoriasis	7.34e-05	0.000284	CcSEcCtD
Diltiazem—Angioedema—Prednisone—psoriasis	7.34e-05	0.000284	CcSEcCtD
Diltiazem—Hypersensitivity—Cyclosporine—psoriasis	7.3e-05	0.000283	CcSEcCtD
Diltiazem—Dyspepsia—Triamcinolone—psoriasis	7.3e-05	0.000282	CcSEcCtD
Diltiazem—Erythema multiforme—Methotrexate—psoriasis	7.29e-05	0.000282	CcSEcCtD
Diltiazem—Nausea—Mycophenolic acid—psoriasis	7.28e-05	0.000282	CcSEcCtD
Diltiazem—Hyperhidrosis—Dexamethasone—psoriasis	7.27e-05	0.000281	CcSEcCtD
Diltiazem—Hyperhidrosis—Betamethasone—psoriasis	7.27e-05	0.000281	CcSEcCtD
Diltiazem—Feeling abnormal—Hydrocortisone—psoriasis	7.26e-05	0.000281	CcSEcCtD
Diltiazem—Malaise—Prednisone—psoriasis	7.24e-05	0.00028	CcSEcCtD
Diltiazem—CACNA1C—Developmental Biology—CARM1—psoriasis	7.23e-05	0.00294	CbGpPWpGaD
Diltiazem—Vertigo—Prednisone—psoriasis	7.21e-05	0.000279	CcSEcCtD
Diltiazem—Eye disorder—Methotrexate—psoriasis	7.2e-05	0.000279	CcSEcCtD
Diltiazem—Syncope—Prednisone—psoriasis	7.2e-05	0.000279	CcSEcCtD
Diltiazem—Tinnitus—Methotrexate—psoriasis	7.19e-05	0.000278	CcSEcCtD
Diltiazem—Anorexia—Dexamethasone—psoriasis	7.17e-05	0.000278	CcSEcCtD
Diltiazem—Anorexia—Betamethasone—psoriasis	7.17e-05	0.000278	CcSEcCtD
Diltiazem—Urticaria—Prednisolone—psoriasis	7.16e-05	0.000277	CcSEcCtD
Diltiazem—Cardiac disorder—Methotrexate—psoriasis	7.15e-05	0.000277	CcSEcCtD
Diltiazem—Fatigue—Triamcinolone—psoriasis	7.15e-05	0.000277	CcSEcCtD
Diltiazem—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.12e-05	0.000276	CcSEcCtD
Diltiazem—Asthenia—Cyclosporine—psoriasis	7.11e-05	0.000275	CcSEcCtD
Diltiazem—Pain—Triamcinolone—psoriasis	7.09e-05	0.000274	CcSEcCtD
Diltiazem—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.09e-05	0.00288	CbGpPWpGaD
Diltiazem—Loss of consciousness—Prednisone—psoriasis	7.06e-05	0.000273	CcSEcCtD
Diltiazem—Hypotension—Dexamethasone—psoriasis	7.03e-05	0.000272	CcSEcCtD
Diltiazem—Hypotension—Betamethasone—psoriasis	7.03e-05	0.000272	CcSEcCtD
Diltiazem—Pruritus—Cyclosporine—psoriasis	7.01e-05	0.000271	CcSEcCtD
Diltiazem—Urticaria—Hydrocortisone—psoriasis	7e-05	0.000271	CcSEcCtD
Diltiazem—Angiopathy—Methotrexate—psoriasis	6.99e-05	0.000271	CcSEcCtD
Diltiazem—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.99e-05	0.00284	CbGpPWpGaD
Diltiazem—Body temperature increased—Hydrocortisone—psoriasis	6.96e-05	0.000269	CcSEcCtD
Diltiazem—Abdominal pain—Hydrocortisone—psoriasis	6.96e-05	0.000269	CcSEcCtD
Diltiazem—Mediastinal disorder—Methotrexate—psoriasis	6.95e-05	0.000269	CcSEcCtD
Diltiazem—Asthenia—Mycophenolate mofetil—psoriasis	6.93e-05	0.000268	CcSEcCtD
Diltiazem—CACNA1C—Alzheimers Disease—TNF—psoriasis	6.93e-05	0.00282	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—NDUFA5—psoriasis	6.93e-05	0.00282	CbGpPWpGaD
Diltiazem—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.85e-05	0.000265	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Betamethasone—psoriasis	6.85e-05	0.000265	CcSEcCtD
Diltiazem—Pruritus—Mycophenolate mofetil—psoriasis	6.84e-05	0.000265	CcSEcCtD
Diltiazem—Arthralgia—Prednisone—psoriasis	6.83e-05	0.000264	CcSEcCtD
Diltiazem—Myalgia—Prednisone—psoriasis	6.83e-05	0.000264	CcSEcCtD
Diltiazem—Feeling abnormal—Triamcinolone—psoriasis	6.83e-05	0.000264	CcSEcCtD
Diltiazem—Alopecia—Methotrexate—psoriasis	6.81e-05	0.000264	CcSEcCtD
Diltiazem—Insomnia—Betamethasone—psoriasis	6.8e-05	0.000263	CcSEcCtD
Diltiazem—Insomnia—Dexamethasone—psoriasis	6.8e-05	0.000263	CcSEcCtD
Diltiazem—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.8e-05	0.00276	CbGpPWpGaD
Diltiazem—Diarrhoea—Cyclosporine—psoriasis	6.78e-05	0.000262	CcSEcCtD
Diltiazem—Paraesthesia—Dexamethasone—psoriasis	6.76e-05	0.000261	CcSEcCtD
Diltiazem—Paraesthesia—Betamethasone—psoriasis	6.76e-05	0.000261	CcSEcCtD
Diltiazem—Discomfort—Prednisone—psoriasis	6.75e-05	0.000261	CcSEcCtD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.72e-05	0.00273	CbGpPWpGaD
Diltiazem—Malnutrition—Methotrexate—psoriasis	6.71e-05	0.00026	CcSEcCtD
Diltiazem—Erythema—Methotrexate—psoriasis	6.71e-05	0.00026	CcSEcCtD
Diltiazem—Hypersensitivity—Prednisolone—psoriasis	6.64e-05	0.000257	CcSEcCtD
Diltiazem—Dyspepsia—Dexamethasone—psoriasis	6.62e-05	0.000256	CcSEcCtD
Diltiazem—Dyspepsia—Betamethasone—psoriasis	6.62e-05	0.000256	CcSEcCtD
Diltiazem—Diarrhoea—Mycophenolate mofetil—psoriasis	6.61e-05	0.000256	CcSEcCtD
Diltiazem—Urticaria—Triamcinolone—psoriasis	6.59e-05	0.000255	CcSEcCtD
Diltiazem—Dysgeusia—Methotrexate—psoriasis	6.57e-05	0.000254	CcSEcCtD
Diltiazem—Body temperature increased—Triamcinolone—psoriasis	6.55e-05	0.000254	CcSEcCtD
Diltiazem—Dizziness—Cyclosporine—psoriasis	6.55e-05	0.000254	CcSEcCtD
Diltiazem—Oedema—Prednisone—psoriasis	6.55e-05	0.000254	CcSEcCtD
Diltiazem—Decreased appetite—Dexamethasone—psoriasis	6.54e-05	0.000253	CcSEcCtD
Diltiazem—Decreased appetite—Betamethasone—psoriasis	6.54e-05	0.000253	CcSEcCtD
Diltiazem—Infection—Prednisone—psoriasis	6.51e-05	0.000252	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Betamethasone—psoriasis	6.5e-05	0.000251	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Dexamethasone—psoriasis	6.5e-05	0.000251	CcSEcCtD
Diltiazem—Hypersensitivity—Hydrocortisone—psoriasis	6.49e-05	0.000251	CcSEcCtD
Diltiazem—Fatigue—Dexamethasone—psoriasis	6.49e-05	0.000251	CcSEcCtD
Diltiazem—Fatigue—Betamethasone—psoriasis	6.49e-05	0.000251	CcSEcCtD
Diltiazem—Shock—Prednisone—psoriasis	6.45e-05	0.000249	CcSEcCtD
Diltiazem—Pain—Dexamethasone—psoriasis	6.43e-05	0.000249	CcSEcCtD
Diltiazem—Pain—Betamethasone—psoriasis	6.43e-05	0.000249	CcSEcCtD
Diltiazem—Nervous system disorder—Prednisone—psoriasis	6.43e-05	0.000249	CcSEcCtD
Diltiazem—Tachycardia—Prednisone—psoriasis	6.39e-05	0.000247	CcSEcCtD
Diltiazem—Dizziness—Mycophenolate mofetil—psoriasis	6.39e-05	0.000247	CcSEcCtD
Diltiazem—Hyperhidrosis—Prednisone—psoriasis	6.33e-05	0.000245	CcSEcCtD
Diltiazem—Vision blurred—Methotrexate—psoriasis	6.32e-05	0.000245	CcSEcCtD
Diltiazem—Asthenia—Hydrocortisone—psoriasis	6.32e-05	0.000245	CcSEcCtD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—IL6—psoriasis	6.31e-05	0.00256	CbGpPWpGaD
Diltiazem—Vomiting—Cyclosporine—psoriasis	6.3e-05	0.000244	CcSEcCtD
Diltiazem—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	6.25e-05	0.00254	CbGpPWpGaD
Diltiazem—Rash—Cyclosporine—psoriasis	6.25e-05	0.000242	CcSEcCtD
Diltiazem—Anorexia—Prednisone—psoriasis	6.25e-05	0.000242	CcSEcCtD
Diltiazem—Dermatitis—Cyclosporine—psoriasis	6.24e-05	0.000242	CcSEcCtD
Diltiazem—Pruritus—Hydrocortisone—psoriasis	6.23e-05	0.000241	CcSEcCtD
Diltiazem—Ill-defined disorder—Methotrexate—psoriasis	6.23e-05	0.000241	CcSEcCtD
Diltiazem—Headache—Cyclosporine—psoriasis	6.21e-05	0.00024	CcSEcCtD
Diltiazem—Feeling abnormal—Dexamethasone—psoriasis	6.2e-05	0.00024	CcSEcCtD
Diltiazem—Feeling abnormal—Betamethasone—psoriasis	6.2e-05	0.00024	CcSEcCtD
Diltiazem—Vomiting—Mycophenolate mofetil—psoriasis	6.15e-05	0.000238	CcSEcCtD
Diltiazem—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.12e-05	0.00249	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—TP53—psoriasis	6.11e-05	0.00248	CbGpPWpGaD
Diltiazem—Hypersensitivity—Triamcinolone—psoriasis	6.11e-05	0.000236	CcSEcCtD
Diltiazem—Rash—Mycophenolate mofetil—psoriasis	6.09e-05	0.000236	CcSEcCtD
Diltiazem—Dermatitis—Mycophenolate mofetil—psoriasis	6.09e-05	0.000236	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—IL10—psoriasis	6.08e-05	0.00247	CbGpPWpGaD
Diltiazem—Headache—Mycophenolate mofetil—psoriasis	6.06e-05	0.000234	CcSEcCtD
Diltiazem—Malaise—Methotrexate—psoriasis	6.05e-05	0.000234	CcSEcCtD
Diltiazem—Vertigo—Methotrexate—psoriasis	6.03e-05	0.000233	CcSEcCtD
Diltiazem—Diarrhoea—Hydrocortisone—psoriasis	6.03e-05	0.000233	CcSEcCtD
Diltiazem—Leukopenia—Methotrexate—psoriasis	6.01e-05	0.000232	CcSEcCtD
Diltiazem—Urticaria—Betamethasone—psoriasis	5.98e-05	0.000231	CcSEcCtD
Diltiazem—Urticaria—Dexamethasone—psoriasis	5.98e-05	0.000231	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Prednisone—psoriasis	5.97e-05	0.000231	CcSEcCtD
Diltiazem—Dizziness—Prednisolone—psoriasis	5.96e-05	0.000231	CcSEcCtD
Diltiazem—Asthenia—Triamcinolone—psoriasis	5.95e-05	0.00023	CcSEcCtD
Diltiazem—Body temperature increased—Betamethasone—psoriasis	5.95e-05	0.00023	CcSEcCtD
Diltiazem—Body temperature increased—Dexamethasone—psoriasis	5.95e-05	0.00023	CcSEcCtD
Diltiazem—Abdominal pain—Dexamethasone—psoriasis	5.95e-05	0.00023	CcSEcCtD
Diltiazem—Abdominal pain—Betamethasone—psoriasis	5.95e-05	0.00023	CcSEcCtD
Diltiazem—Insomnia—Prednisone—psoriasis	5.93e-05	0.000229	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—IL4—psoriasis	5.92e-05	0.00241	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CYP2S1—psoriasis	5.89e-05	0.0024	CbGpPWpGaD
Diltiazem—Nausea—Cyclosporine—psoriasis	5.89e-05	0.000228	CcSEcCtD
Diltiazem—Paraesthesia—Prednisone—psoriasis	5.88e-05	0.000228	CcSEcCtD
Diltiazem—Pruritus—Triamcinolone—psoriasis	5.87e-05	0.000227	CcSEcCtD
Diltiazem—Cough—Methotrexate—psoriasis	5.85e-05	0.000227	CcSEcCtD
Diltiazem—Dizziness—Hydrocortisone—psoriasis	5.82e-05	0.000225	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.79e-05	0.00235	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.78e-05	0.00235	CbGpPWpGaD
Diltiazem—Dyspepsia—Prednisone—psoriasis	5.77e-05	0.000223	CcSEcCtD
Diltiazem—Nausea—Mycophenolate mofetil—psoriasis	5.74e-05	0.000222	CcSEcCtD
Diltiazem—Arthralgia—Methotrexate—psoriasis	5.71e-05	0.000221	CcSEcCtD
Diltiazem—Chest pain—Methotrexate—psoriasis	5.71e-05	0.000221	CcSEcCtD
Diltiazem—Myalgia—Methotrexate—psoriasis	5.71e-05	0.000221	CcSEcCtD
Diltiazem—Decreased appetite—Prednisone—psoriasis	5.7e-05	0.00022	CcSEcCtD
Diltiazem—Rash—Prednisolone—psoriasis	5.69e-05	0.00022	CcSEcCtD
Diltiazem—Dermatitis—Prednisolone—psoriasis	5.68e-05	0.00022	CcSEcCtD
Diltiazem—Fatigue—Prednisone—psoriasis	5.65e-05	0.000219	CcSEcCtD
Diltiazem—Headache—Prednisolone—psoriasis	5.65e-05	0.000219	CcSEcCtD
Diltiazem—Discomfort—Methotrexate—psoriasis	5.64e-05	0.000218	CcSEcCtD
Diltiazem—Constipation—Prednisone—psoriasis	5.6e-05	0.000217	CcSEcCtD
Diltiazem—Vomiting—Hydrocortisone—psoriasis	5.6e-05	0.000217	CcSEcCtD
Diltiazem—Rash—Hydrocortisone—psoriasis	5.55e-05	0.000215	CcSEcCtD
Diltiazem—Dermatitis—Hydrocortisone—psoriasis	5.55e-05	0.000215	CcSEcCtD
Diltiazem—Headache—Hydrocortisone—psoriasis	5.52e-05	0.000213	CcSEcCtD
Diltiazem—Dizziness—Triamcinolone—psoriasis	5.48e-05	0.000212	CcSEcCtD
Diltiazem—Infection—Methotrexate—psoriasis	5.44e-05	0.000211	CcSEcCtD
Diltiazem—Feeling abnormal—Prednisone—psoriasis	5.4e-05	0.000209	CcSEcCtD
Diltiazem—Asthenia—Dexamethasone—psoriasis	5.4e-05	0.000209	CcSEcCtD
Diltiazem—Asthenia—Betamethasone—psoriasis	5.4e-05	0.000209	CcSEcCtD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.39e-05	0.00219	CbGpPWpGaD
Diltiazem—Nervous system disorder—Methotrexate—psoriasis	5.37e-05	0.000208	CcSEcCtD
Diltiazem—Thrombocytopenia—Methotrexate—psoriasis	5.36e-05	0.000207	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.36e-05	0.00218	CbGpPWpGaD
Diltiazem—Nausea—Prednisolone—psoriasis	5.36e-05	0.000207	CcSEcCtD
Diltiazem—Pruritus—Betamethasone—psoriasis	5.32e-05	0.000206	CcSEcCtD
Diltiazem—Pruritus—Dexamethasone—psoriasis	5.32e-05	0.000206	CcSEcCtD
Diltiazem—Hyperhidrosis—Methotrexate—psoriasis	5.29e-05	0.000205	CcSEcCtD
Diltiazem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.27e-05	0.00214	CbGpPWpGaD
Diltiazem—Vomiting—Triamcinolone—psoriasis	5.27e-05	0.000204	CcSEcCtD
Diltiazem—Nausea—Hydrocortisone—psoriasis	5.23e-05	0.000202	CcSEcCtD
Diltiazem—Rash—Triamcinolone—psoriasis	5.23e-05	0.000202	CcSEcCtD
Diltiazem—Dermatitis—Triamcinolone—psoriasis	5.22e-05	0.000202	CcSEcCtD
Diltiazem—Anorexia—Methotrexate—psoriasis	5.22e-05	0.000202	CcSEcCtD
Diltiazem—Urticaria—Prednisone—psoriasis	5.2e-05	0.000201	CcSEcCtD
Diltiazem—Headache—Triamcinolone—psoriasis	5.19e-05	0.000201	CcSEcCtD
Diltiazem—CACNA1S—Axon guidance—TYK2—psoriasis	5.18e-05	0.00211	CbGpPWpGaD
Diltiazem—Abdominal pain—Prednisone—psoriasis	5.18e-05	0.0002	CcSEcCtD
Diltiazem—Body temperature increased—Prednisone—psoriasis	5.18e-05	0.0002	CcSEcCtD
Diltiazem—Diarrhoea—Dexamethasone—psoriasis	5.15e-05	0.000199	CcSEcCtD
Diltiazem—Diarrhoea—Betamethasone—psoriasis	5.15e-05	0.000199	CcSEcCtD
Diltiazem—Hypotension—Methotrexate—psoriasis	5.12e-05	0.000198	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Methotrexate—psoriasis	4.99e-05	0.000193	CcSEcCtD
Diltiazem—Dizziness—Betamethasone—psoriasis	4.98e-05	0.000193	CcSEcCtD
Diltiazem—Dizziness—Dexamethasone—psoriasis	4.98e-05	0.000193	CcSEcCtD
Diltiazem—Insomnia—Methotrexate—psoriasis	4.95e-05	0.000192	CcSEcCtD
Diltiazem—Nausea—Triamcinolone—psoriasis	4.93e-05	0.000191	CcSEcCtD
Diltiazem—Paraesthesia—Methotrexate—psoriasis	4.92e-05	0.00019	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.9e-05	0.00199	CbGpPWpGaD
Diltiazem—Dyspnoea—Methotrexate—psoriasis	4.88e-05	0.000189	CcSEcCtD
Diltiazem—Somnolence—Methotrexate—psoriasis	4.87e-05	0.000188	CcSEcCtD
Diltiazem—CACNA1S—Developmental Biology—LEP—psoriasis	4.85e-05	0.00197	CbGpPWpGaD
Diltiazem—Hypersensitivity—Prednisone—psoriasis	4.83e-05	0.000187	CcSEcCtD
Diltiazem—Dyspepsia—Methotrexate—psoriasis	4.82e-05	0.000187	CcSEcCtD
Diltiazem—Vomiting—Betamethasone—psoriasis	4.78e-05	0.000185	CcSEcCtD
Diltiazem—Vomiting—Dexamethasone—psoriasis	4.78e-05	0.000185	CcSEcCtD
Diltiazem—Decreased appetite—Methotrexate—psoriasis	4.76e-05	0.000184	CcSEcCtD
Diltiazem—Rash—Dexamethasone—psoriasis	4.74e-05	0.000184	CcSEcCtD
Diltiazem—Rash—Betamethasone—psoriasis	4.74e-05	0.000184	CcSEcCtD
Diltiazem—Dermatitis—Betamethasone—psoriasis	4.74e-05	0.000183	CcSEcCtD
Diltiazem—Dermatitis—Dexamethasone—psoriasis	4.74e-05	0.000183	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Methotrexate—psoriasis	4.73e-05	0.000183	CcSEcCtD
Diltiazem—Fatigue—Methotrexate—psoriasis	4.72e-05	0.000183	CcSEcCtD
Diltiazem—Headache—Dexamethasone—psoriasis	4.71e-05	0.000182	CcSEcCtD
Diltiazem—Headache—Betamethasone—psoriasis	4.71e-05	0.000182	CcSEcCtD
Diltiazem—Asthenia—Prednisone—psoriasis	4.7e-05	0.000182	CcSEcCtD
Diltiazem—Pain—Methotrexate—psoriasis	4.68e-05	0.000181	CcSEcCtD
Diltiazem—Pruritus—Prednisone—psoriasis	4.64e-05	0.000179	CcSEcCtD
Diltiazem—Feeling abnormal—Methotrexate—psoriasis	4.51e-05	0.000175	CcSEcCtD
Diltiazem—Diarrhoea—Prednisone—psoriasis	4.48e-05	0.000173	CcSEcCtD
Diltiazem—Nausea—Dexamethasone—psoriasis	4.47e-05	0.000173	CcSEcCtD
Diltiazem—Nausea—Betamethasone—psoriasis	4.47e-05	0.000173	CcSEcCtD
Diltiazem—Urticaria—Methotrexate—psoriasis	4.35e-05	0.000168	CcSEcCtD
Diltiazem—Dizziness—Prednisone—psoriasis	4.33e-05	0.000168	CcSEcCtD
Diltiazem—Body temperature increased—Methotrexate—psoriasis	4.33e-05	0.000168	CcSEcCtD
Diltiazem—Abdominal pain—Methotrexate—psoriasis	4.33e-05	0.000168	CcSEcCtD
Diltiazem—CYP3A7—Metabolism—NDUFA5—psoriasis	4.24e-05	0.00172	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—PPARG—psoriasis	4.22e-05	0.00172	CbGpPWpGaD
Diltiazem—Vomiting—Prednisone—psoriasis	4.17e-05	0.000161	CcSEcCtD
Diltiazem—Rash—Prednisone—psoriasis	4.13e-05	0.00016	CcSEcCtD
Diltiazem—Dermatitis—Prednisone—psoriasis	4.13e-05	0.00016	CcSEcCtD
Diltiazem—Headache—Prednisone—psoriasis	4.1e-05	0.000159	CcSEcCtD
Diltiazem—Hypersensitivity—Methotrexate—psoriasis	4.03e-05	0.000156	CcSEcCtD
Diltiazem—Asthenia—Methotrexate—psoriasis	3.93e-05	0.000152	CcSEcCtD
Diltiazem—Nausea—Prednisone—psoriasis	3.89e-05	0.000151	CcSEcCtD
Diltiazem—Pruritus—Methotrexate—psoriasis	3.87e-05	0.00015	CcSEcCtD
Diltiazem—Diarrhoea—Methotrexate—psoriasis	3.75e-05	0.000145	CcSEcCtD
Diltiazem—CACNA1S—Developmental Biology—TYK2—psoriasis	3.7e-05	0.0015	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—TYK2—psoriasis	3.7e-05	0.0015	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—VEGFA—psoriasis	3.67e-05	0.00149	CbGpPWpGaD
Diltiazem—Dizziness—Methotrexate—psoriasis	3.62e-05	0.00014	CcSEcCtD
Diltiazem—CYP3A7—Metabolism—CYP2S1—psoriasis	3.61e-05	0.00147	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IFNG—psoriasis	3.58e-05	0.00145	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.57e-05	0.00145	CbGpPWpGaD
Diltiazem—Vomiting—Methotrexate—psoriasis	3.48e-05	0.000135	CcSEcCtD
Diltiazem—CACNA1C—Developmental Biology—LEP—psoriasis	3.46e-05	0.00141	CbGpPWpGaD
Diltiazem—Rash—Methotrexate—psoriasis	3.45e-05	0.000134	CcSEcCtD
Diltiazem—Dermatitis—Methotrexate—psoriasis	3.45e-05	0.000133	CcSEcCtD
Diltiazem—Headache—Methotrexate—psoriasis	3.43e-05	0.000133	CcSEcCtD
Diltiazem—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.33e-05	0.00135	CbGpPWpGaD
Diltiazem—Nausea—Methotrexate—psoriasis	3.25e-05	0.000126	CcSEcCtD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.12e-05	0.00127	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NDUFA5—psoriasis	3.07e-05	0.00125	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—PPARG—psoriasis	3.01e-05	0.00122	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—NFKB1—psoriasis	2.88e-05	0.00117	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CARM1—psoriasis	2.88e-05	0.00117	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.74e-05	0.00111	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.7e-05	0.0011	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NDUFA5—psoriasis	2.66e-05	0.00108	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TYK2—psoriasis	2.64e-05	0.00107	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—VEGFA—psoriasis	2.62e-05	0.00106	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—VEGFA—psoriasis	2.61e-05	0.00106	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP2S1—psoriasis	2.61e-05	0.00106	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—STAT3—psoriasis	2.59e-05	0.00105	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—IL6—psoriasis	2.54e-05	0.00103	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.48e-05	0.00101	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NDUFA5—psoriasis	2.37e-05	0.000964	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—TNF—psoriasis	2.32e-05	0.000941	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NDUFA5—psoriasis	2.31e-05	0.000941	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.3e-05	0.000936	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP2S1—psoriasis	2.26e-05	0.000918	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—TNF—psoriasis	2.24e-05	0.000911	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.21e-05	0.000899	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NDUFA5—psoriasis	2.18e-05	0.000887	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NDUFA5—psoriasis	2.16e-05	0.000879	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.15e-05	0.000874	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—NFKB1—psoriasis	2.06e-05	0.000836	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.05e-05	0.000834	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP2S1—psoriasis	2.02e-05	0.00082	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.02e-05	0.00082	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP2S1—psoriasis	1.97e-05	0.0008	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—VEGFA—psoriasis	1.87e-05	0.000759	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP2S1—psoriasis	1.85e-05	0.000754	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—STAT3—psoriasis	1.85e-05	0.000751	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP2S1—psoriasis	1.84e-05	0.000747	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—IL6—psoriasis	1.81e-05	0.000735	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—IL6—psoriasis	1.81e-05	0.000735	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CAT—psoriasis	1.77e-05	0.000719	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CARM1—psoriasis	1.76e-05	0.000716	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TNF—psoriasis	1.6e-05	0.00065	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.53e-05	0.00062	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.47e-05	0.000597	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NDUFA5—psoriasis	1.43e-05	0.00058	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—APOE—psoriasis	1.38e-05	0.000559	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.33e-05	0.000542	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—IL6—psoriasis	1.29e-05	0.000525	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CARM1—psoriasis	1.27e-05	0.000518	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP2S1—psoriasis	1.21e-05	0.000493	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PPARG—psoriasis	1.2e-05	0.000487	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.18e-05	0.000481	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.14e-05	0.000464	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CARM1—psoriasis	1.1e-05	0.000448	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CAT—psoriasis	1.08e-05	0.000441	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.06e-05	0.00043	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.03e-05	0.000419	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.01e-05	0.000409	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CARM1—psoriasis	9.85e-06	0.0004	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.63e-06	0.000392	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CARM1—psoriasis	9.61e-06	0.000391	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.2e-06	0.000374	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CARM1—psoriasis	9.06e-06	0.000368	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CARM1—psoriasis	8.98e-06	0.000365	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—APOE—psoriasis	8.42e-06	0.000342	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.39e-06	0.000341	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CAT—psoriasis	7.83e-06	0.000318	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PPARG—psoriasis	7.33e-06	0.000298	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CAT—psoriasis	6.79e-06	0.000276	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—APOE—psoriasis	6.09e-06	0.000247	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CAT—psoriasis	6.06e-06	0.000246	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CARM1—psoriasis	5.92e-06	0.000241	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CAT—psoriasis	5.91e-06	0.00024	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CAT—psoriasis	5.57e-06	0.000226	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CAT—psoriasis	5.52e-06	0.000224	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PPARG—psoriasis	5.3e-06	0.000216	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—APOE—psoriasis	5.27e-06	0.000214	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—APOE—psoriasis	4.71e-06	0.000191	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—APOE—psoriasis	4.59e-06	0.000187	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PPARG—psoriasis	4.59e-06	0.000187	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—APOE—psoriasis	4.33e-06	0.000176	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—APOE—psoriasis	4.29e-06	0.000174	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PPARG—psoriasis	4.1e-06	0.000167	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PPARG—psoriasis	4e-06	0.000163	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PPARG—psoriasis	3.77e-06	0.000153	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PPARG—psoriasis	3.74e-06	0.000152	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CAT—psoriasis	3.64e-06	0.000148	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—APOE—psoriasis	2.83e-06	0.000115	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PPARG—psoriasis	2.46e-06	0.0001	CbGpPWpGaD
